Cargando…
An IL-2-grafted antibody immunotherapy with potent efficacy against metastatic cancer
Modified interleukin-2 (IL-2) formulations are being tested in cancer patients. However, IL-2 immunotherapy damages IL-2 receptor (IL-2R)-positive endothelial cells and stimulates IL-2Rα (CD25)-expressing lymphocytes that curtail anti-tumor responses. A first generation of IL-2Rβ (CD122)-biased IL-2...
Autores principales: | Sahin, Dilara, Arenas-Ramirez, Natalia, Rath, Matthias, Karakus, Ufuk, Hümbelin, Monika, van Gogh, Merel, Borsig, Lubor, Boyman, Onur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755894/ https://www.ncbi.nlm.nih.gov/pubmed/33353953 http://dx.doi.org/10.1038/s41467-020-20220-1 |
Ejemplares similares
-
Tumor Cell–Intrinsic c-Myb Upregulation Stimulates Antitumor Immunity in a Murine Colorectal Cancer Model
por: van Gogh, Merel, et al.
Publicado: (2023) -
TGFβ Signaling in Myeloid Cells Promotes Lung and Liver Metastasis Through Different Mechanisms
por: Stefanescu, Cristina, et al.
Publicado: (2021) -
The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis
por: Roblek, Marko, et al.
Publicado: (2022) -
Treg-selective IL-2 starvation synergizes with CD40 activation to sustain durable responses in lymphoma models
por: Stirm, Kristin, et al.
Publicado: (2023) -
Cancer Cell Adhesion and Metastasis: Selectins, Integrins, and the Inhibitory Potential of Heparins
por: Bendas, Gerd, et al.
Publicado: (2012)